Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Laetus and STADA partner for implementation of EU FMD - Label and Narrow Web
Breaking News, Industry News

Laetus and STADA partner for implementation of EU FMD

By February 2019, pharmaceutical companies in Europe must have implemented specified regulations.

By February 2019, pharmaceutical companies that manufacture or sell their products in Europe must have implemented the regulations specified in the EU Falsification Directive (FMD). This includes the traceability (Track and Trace) of prescription drugs back to the manufacturer.

STADA Arzneimittel AG responded to these requirements early on and initiated the appropriate measures. For the implementation of the serialization requirements according to EU-FMD, the manufacturer of generics and OTC brand products relies on Laetus GmbH as its partner. The project covers a total of 30 lines at the sites in Germany, Serbia, Montenegro, UK and Russia and involves a good deal of close collaboration.

In choosing Laetus, STADA Arzneimittel AG is placing its trust in a reliable partner with a proven ability to implement serialization projects of this scale and deliver success – backed up by more than 40 years‘ experience of inline quality control and hundreds of successful track and trace installations.

In addition to Secure Track & Trace software (S-TTS), Laetus also offers, among other things, some 20 MV-70-F pack handling systems with integrated weighing and manipulation protection functions (tamper-evident labelling). This machine is particularly suited to integration into existing packaging lines, thanks to its compact dimensions.

Add us as a preferred source on Google

Get the latest Label and Narrow Web news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Label and Narrow Web Newsletters